Skip to content

Services

A busy man needing an outsourced accounting

4 Reasons the Outsourced Finance Function Is Trending

Discover the four reasons why outsourcing finance functions is becoming a trend, and why businesses of all sizes can benefit from it. The outsourced finance function can help businesses save money, free up time and resources, improve efficiency, and gain access to expert knowledge and advice. Implementing an outsourced finance function can help businesses of all sizes take their operations to the next level.

data-man-working-on-a-cafe.jpg

How Scrubbed Visualizes Big Data for Clients?

The solution to better data analysis is to find a system that can consolidate data across all entities and deliver it in a visual format. This allows clients to glean insights at a glance. Scrubbed has been doing this for its clients. In this blog, you’ll learn how we can help your business too!

client and business owner shaking hands during onboarding - Scrubbed 2022

Outsourcing for CPA Firms: 5 Steps to a Successful Onboarding

Outsourcing for CPA firms can be a great way to improve efficiency and bottom line results. However, it’s important to carefully consider all aspects of the outsourcing relationship before taking the plunge. In this blog, we’ll teach you the 5 steps to a successful Onboarding.

Taking a good, hard look at finances to figure out how the business is doing_Scrubbed

What Types of Reporting are Important to Investors?

In order to make informed decisions, Investors need access to financial and non-financial information about the companies they are considering investing in. What are these types of reports and how to prepare it? Read the full blog to find out.

Scrubbed blog - Biotechnology Expert looking at a microscope

Why the Right Financial Plan is Critical for Biotech Startups

Given the current market conditions, a slowdown in private equity investment within the sector is to be expected. As such, the funding environment for the remainder of 2022 is likely to look much different than what we’ve seen in recent quarters. What that means for early-stage biotech startups is that raising a new round of funding over the next year could become much harder and take longer than expected.